Abstract
Vitamin B3 (niacin) deficiency can cause pellagra with symptoms of dermatitis, diarrhea and dementia. However, it is unclear whether the vitamin B3 deficiency causes human aging. FK866 (a Nampt inhibitor) can reduce intracellular NAD+ level and induce senescence of human Hs68 cells. However, the mechanisms underlying FK866-induced senescence of Hs68 cells are unclear. In this study, we used FK866 to mimic the effects of vitamin B3 deficiency to reduce the NAD+ level and investigated the mechanisms of FK866-induced senescence of Hs68 cells. We hypothesized that FK866 induced the senescence of Hs68 cells via an attenuation of NAD+-silent information regulator T1 (SIRT1) signaling. We found that FK866 induced cell senescence and diminished cellular NAD+ levels and SIRT1 activity (detected by acetylation of p53), and these effects were dramatically antagonized by co-treatment with nicotinic acid, nicotinamide, or NAD+. In contrast, the protein expression of SIRT1, AMP-activated protein kinase, mammalian target of rapamycin, and nicotinamide phosphoribosyltransferase (Nampt) was not affected by FK866. In addition, the role of GSH in the FK866-induced cells senescence may be limited, as N-acetylcysteine did not antagonize FK866-induced cell senescence. These results suggest that FK866 induces cell senescence via attenuation of NAD+-SIRT1 signaling. The effects of vitamin B3 deficiency on human aging warrant further investigation.
Similar content being viewed by others
References
Atkuri KR, Mantovani JJ, Herzenberg LA, Herzenberg LA (2007) N-Acetylcysteine–a safe antidote for cysteine/glutathione deficiency. Curr Opin Pharmacol 7:355–359. doi:10.1016/j.coph.2007.04.005
Badawy AA (2014) Pellagra and alcoholism: a biochemical perspective. Alcohol Alcohol 49:238–250. doi:10.1093/alcalc/agu010
Billington RA, Travelli C, Ercolano E, Galli U, Roman CB, Grolla AA, Canonico PL, Condorelli F, Genazzani AA (2008) Characterization of NAD uptake in mammalian cells. J Biol Chem 283:6367–6374. doi:10.1074/jbc.M706204200
Bogan KL, Brenner C (2008) Nicotinic acid, nicotinamide, and nicotinamide riboside: a molecular evaluation of NAD+ precursor vitamins in human nutrition. Annu Rev Nutr 28:115–130. doi:10.1146/annurev.nutr.28.061807.155443
Donmez G, Guarente L (2010) Aging and disease: connections to sirtuins. Aging Cell 9:285–290. doi:10.1111/j.1474-9726.2010.00548.x
Frye RA (2000) Phylogenetic classification of prokaryotic and eukaryotic Sir2-like proteins. Biochem Biophys Res Commun 273:793–798. doi:10.1006/bbrc.2000.3000
Ghosh HS, McBurney M, Robbins PD (2010) SIRT1 negatively regulates the mammalian target of rapamycin. PLoS ONE 5:e9199. doi:10.1371/journal.pone.0009199
Haigis MC, Sinclair DA (2010) Mammalian sirtuins: biological insights and disease relevance. Annu Rev Pathol 5:253–295. doi:10.1146/annurev.pathol.4.110807.092250
Hasmann M, Schemainda I (2003) FK866, a highly specific noncompetitive inhibitor of nicotinamide phosphoribosyltransferase, represents a novel mechanism for induction of tumor cell apoptosis. Cancer Res 63:7436–7442
Imai S (2011) Dissecting systemic control of metabolism and aging in the NAD World: the importance of SIRT1 and NAMPT-mediated NAD biosynthesis. FEBS Lett 585:1657–1662. doi:10.1016/j.febslet.2011.04.060
Leibiger IB, Berggren PO (2006) Sirt1: a metabolic master switch that modulates lifespan. Nat Med 12:34–36. doi:10.1038/nm0106-34
Lin SJ, Guarente L (2003) Nicotinamide adenine dinucleotide, a metabolic regulator of transcription, longevity and disease. Curr Opin Cell Biol 15:241–246. doi:10.1016/S0955-0674(03)00006-1
Pillai VB, Sundaresan NR, Kim G, Gupta M, Rajamohan SB, Pillai JB, Samant S, Ravindra PV, Isbatan A, Gupta MP (2010) Exogenous NAD blocks cardiac hypertrophic response via activation of the SIRT3-LKB1-AMP-activated kinase pathway. J Biol Chem 285:3133–3144. doi:10.1074/jbc.M109.077271
Pittelli M, Formentini L, Faraco G, Lapucci A, Rapizzi E, Cialdai F, Romano G, Moneti G, Moroni F, Chiarugi A (2010) Inhibition of nicotinamide phosphoribosyltransferase: cellular bioenergetics reveals a mitochondrial insensitive NAD pool. J Biol Chem 285:34106–34114. doi:10.1074/jbc.M110.136739
Ruderman NB, Xu XJ, Nelson L, Cacicedo JM, Saha AK, Lan F, Ido Y (2010) AMPK and SIRT1: a long-standing partnership? Am J Physiol Endocrinol Metab 298:E751–E760. doi:10.1152/ajpendo.00745.2009
Salminen A, Kaarniranta K (2012) AMP-activated protein kinase (AMPK) controls the aging process via an integrated signaling network. Ageing Res Rev 11:230–241. doi:10.1016/j.arr.2011.12.005
Sauve AA (2008) NAD+ and vitamin B3: from metabolism to therapies. J Pharmacol Exp Ther 324:883–893. doi:10.1124/jpet.107.120758
Sauve AA, Wolberger C, Schramm VL, Boeke JD (2006) The biochemistry of sirtuins. Annu Rev Biochem 75:435–465. doi:10.1146/annurev.biochem.74.082803.133500
Sinclair DA, Guarente L (2006) Unlocking the secretes of longevity genes. Sci Am 294:48–51. doi:10.1038/scientificamerican1206-68sp
Vaziri H, Dessain SK, Eaton EN, Imai SI, Frye RA, Pandita TK, Guarente L, Weinberg RA (2001) hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase. Cell 107:149–159. doi:10.1016/S0092-8674(01)00527-X
Wang Y, Liang Y, Vanhoutte PM (2011) SIRT1 and AMPK in regulating mammalian senescence: a critical review and a working model. FEBS Lett 585:986–994. doi:10.1016/j.febslet.2010.11.047
Yang NC, Hu ML (2004) A fluorimetric method using fluorescein di-β-D-galactopyranoside for quantifying the senescence associated-β-galactosidase activity in human foreskin fibroblast Hs68 cells. Anal Biochem 325:337–343. doi:10.1016/j.ab.2003.11.012
Yang H, Lavu S, Sinclair DA (2006) Nampt/PBEF/Visfatin: a regulator of mammalian health and longevity? Exp Gerontol 41:718–726. doi:10.1016/j.exger.2006.06.003
Yang NC, Song TY, Chen MY, Hu ML (2011) Effects of 2-deoxyglucose and dehydroepiandrosterone on intracellular NAD(+) level, SIRT1 activity and replicative lifespan of human Hs68 cells. Biogerontology 12:527–536. doi:10.1007/s10522-011-9342-7
Yang NC, Song TY, Chang YZ, Chen MY, Hu ML (2015) Up-regulation of nicotinamide phosphoribosyltransferase and increase of NAD(+) levels by glucose restriction extend replicative lifespan of human fibroblast Hs68 cells. Biogerontology 16:31–42. doi:10.1007/s10522-014-9528-x
Zheng S, Yumei F, Chen A (2007) De novo synthesis of glutathione is a prerequisite for curcumin to inhibit hepatic stellate cell (HSC) activation. Free Radic Biol Med 43:444–453. doi:10.1016/j.freeradbiomed.2007.04.016
Zhuo L, Fu B, Bai X, Zhang B, Wu L, Cui J, Cui S, Wei R, Chen X, Cai G (2011) NAD blocks high glucose induced mesangial hypertrophy via activation of the sirtuins-AMPK-mTOR pathway. Cell Physiol Biochem 27:681–690. doi:10.1159/000330077
Zoncu R, Efeyan A, Sabatini DM (2011) mTOR: from growth signal integration to cancer, diabetes and ageing. Nat Rev Mol Cell Biol 12:21–35. doi:10.1038/nrm3025
Acknowledgments
This work was supported by grants from the National Science Foundation (NSC 102-2320-B-040-016-MY3) Taiwan ROC. The microplate fluorometer and Chemiluminescence Imaging System was performed in the Instrument Center of Chung Shan Medical University, which is supported by National Science Council, Ministry of Education and Chung Shan Medical University.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Song, TY., Yeh, SL., Hu, ML. et al. A Nampt inhibitor FK866 mimics vitamin B3 deficiency by causing senescence of human fibroblastic Hs68 cells via attenuation of NAD+-SIRT1 signaling. Biogerontology 16, 789–800 (2015). https://doi.org/10.1007/s10522-015-9605-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10522-015-9605-9